To clarify whether the senescent tumor cells inhibit T cell activation directly, we analyzed the rate of CD8+ T cell proliferation in the CM from the control (SW480) and from the senescent tumor cells (SW480/ROS). The gene discussed is CD8A; the disease is neoplasm.